The strong concordance between single-cell transcriptional changes, bulk tissue proteomics, and biomarker signatures underscores the breadth of GLP-1R-mediated hepatic reprogramming. Physicians may choose lower doses that avoid the side effects associated with the higher doses needed for significant weight loss, potentially also lowering costs for patients, Drucker suggested adding Were not saying weight loss isnt important because many things improve when patients lose weight
Better Weight Loss Outcomes And More Sustainable Results Yes, GLP-1s are effective
LOXL2-dependent deacetylation of aldolase A induces metabolic reprogramming and tumor progression
In cancer, Kla-driven modulation of ferroptosis has been implicated in developing resistance to chemotherapy and radiation
It's not seen with: Semaglutide (Wegovy/Ozempic): 10% body weight quickly Hypoglycemia (Low Blood Sugar): Rare in non-diabetics ( perceived benefit) Timeline of Side Effects: What to Expect Week by Week Week 14: Initial Dose (2mg) What's happening: Body adjusting to GLP-1 activation Common side effects: Mild nausea (2030%): Usually 12 hours after injection Reduced appetite (desired!) Occasional loose stools Mild fatigue Duration: Usually 25 days after each injection, then improves Management: Take with food, stay hydrated, avoid high-fat meals Week 58: First Dose Increase (4mg) What's happening: GLP-1 effects intensifying Common side effects: Nausea increases (3040%) Diarrhea or constipation (1525%) Fullness sensation (desired effect) Energy fluctuations Duration: Peak in first 23 days after dose increase, then stabilizes Management: Smaller, more frequent meals